We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Phase III Failure Bruises Eli Lilly’s Blissful 2014 Outlook
Phase III Failure Bruises Eli Lilly’s Blissful 2014 Outlook
Eli Lilly’s plans for strong sales growth in 2014 have been set back, with the drugmaker saying Thursday its promising depression treatment edivoxetine has failed in late-stage testing.